Evidence map›Paper›PMID 37775582›Full record

ArticlePediatric nephrology (Berlin, Germany)2024

Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study.

An Samaey, Jorge Francisco Vázquez-Castellanos, Clara Caenepeel, Pieter Evenepoel, Séverine Vermeire, Jeroen Raes, Noël Knops

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

An Samaey *Department of Pediatric Nephrology and Solid Organ Transplantation, UZ Leuven, Leuven, Belgium. an.samaey@gmail.com.ORCID 0009-0001-6820-8321
Jorge Francisco Vázquez-Castellanos *Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium.
Clara Caenepeel *Translational Research Center for Gastrointestinal Disorders (TARGID), UZ Leuven, Leuven, Belgium.
Pieter EvenepoelDepartment of Nephrology, University Hospitals Leuven, Leuven, Belgium.
Séverine VermeireDepartment of Gastroenterology &, Hepatology University Hospitals Leuven, and Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
Jeroen RaesDepartment of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium.
Noël KnopsDepartment of Pediatric Nephrology and Solid Organ Transplantation, UZ Leuven, Leuven, Belgium.
Rega Institute for Medical Research · BEUniversitair Ziekenhuis Leuven · BEKU Leuven · BELaboratoire de physique des Solides · FR

Funding

FWO Vlaanderen 1236321N
6 · The paper itself

Abstract

backgroundRecurrent Clostridium difficile infection (rCDI) is a rising problem in children with chronic diseases. Fecal microbiota transplantation (FMT) is a recent alternative for rCDI patients who do not respond to conventional treatment. FMT could have an additional positive effect on the intestinal dysbiosis and accumulation of uremic retention molecules (URM) associated with chronic kidney disease (CKD). Our aim was to investigate the clinical efficacy of FMT for rCDI in children with CKD together with the effect on dysbiosis and URM levels.

methodsWe analyzed stool and blood samples before and until 3 months after FMT in 3 children between 4 and 8 years old with CKD and rCDI. The microbiome was analyzed by 16 s rRNA sequencing. URM were analyzed with ultra-performance liquid chromatography-tandem mass spectrometry. CRP and fecal calprotectin were analyzed as parameters for systemic and gut inflammation, respectively.

resultsCDI resolved after FMT in all three without adverse events; one patient needed a second FMT. No significant effect on CRP and calprotectin was observed. Stool samples demonstrated a reduced richness and bacterial diversity which did not improve after FMT. We did observe a trend in the decrease of specific URM up to 3 months after FMT.

conclusionFMT is an effective treatment for rCDI in patients with CKD. Analysis of the microbiome showed an important intestinal dysbiosis that, besides a significant reduction in Clostridium difficile, did not significantly change after FMT. A trend for reduction was seen in some of the measured URM after FMT.

Indexed as

Clostridium InfectionsRenal Insufficiency, ChronicChildChild, PreschoolDysbiosisFecal Microbiota TransplantationHumansLeukocyte L1 Antigen ComplexPilot ProjectsRecurrenceRenal Replacement TherapyTreatment OutcomeLeukocyte L1 Antigen ComplexChronic kidney diseaseClostridium difficileFecal microbiota transplantationUremic retention molecules

Identifiers

PMID37775582
OpenAlexW4387210050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.